2019 Novel corona-virus (2019-nCoV) is considered to be a global risk and put the entire globe into unrest. Specific drug against the virus is unavailable. This tricky situation requires development of pharmacophores for efficient treatment against severe acute 2019-nCoV. The crystal structure of SARS-CoV-2 main protease (M^pro) has been released, thus can be used for fast in silico molecular docking. This may result into identification of active bio-molecules principally phytochemicals. In silico molecular docking revealed that the phytochemical, ferulic acid effectively binds at the active pocket of the SARS-CoV-2 main protease.